Yao Li

机构：China National Pharmaceutical Group Corporation (China) · ORCID：0000-0001-8720-3027

发表论文 190 篇 · 总被引 3311 次 · h-index 31

代表论文

• DeepSeek-V3 Technical Report (2024 · arXiv (Cornell University) · 被引 259)
• Optimization of preparation and transformation of protoplasts from Populus simonii × P. nigra leaves and subcellular localization of the major latex protein 328 (MLP328) (2024 · Plant Methods · 被引 26)
• The potential mechanism of action of gut flora and bile acids through the TGR5/TRPV1 signaling pathway in diabetic peripheral neuropathic pain (2024 · Frontiers in Endocrinology · 被引 17)
• How to effectively mine app reviews concerning software ecosystem? A survey of review characteristics (2024 · Journal of Systems and Software · 被引 7)
• RNA interference-mediated silencing of coat protein II (COPII) genes affects the gut homeostasis and cuticle development in Locusta migratoria (2024 · International Journal of Biological Macromolecules · 被引 7)
• Metformin modulates mitochondrial autophagy in renal tubular epithelial injury induced by high glucose via the Keap1/Nrf2 pathway (2023 · Molecular and Cellular Biochemistry · 被引 7)